Cost-effectiveness of testing for human immunodeficiency virus and hepatitis C virus among blood transfusion recipients

Infection Control and Hospital Epidemiology

Volumn 24, Issue 2, 2003, Pages 132-136

  Mathoulin Pelissier, Simone ^a,c   Salmi, Louis Rachid ^a   Fialon, Pierre ^b   Salamon, Roger ^a  

^a Inst Pub Hlth Epidemiol/Dvmt   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c INSTITUT BERGONIÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ARTICLE; BLOOD TRANSFUSION; COST EFFECTIVENESS ANALYSIS; FRANCE; HEALTH INSURANCE; HEPATITIS C; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; SEROLOGY; TEACHING HOSPITAL; VIRUS DETECTION;

AIDS SERODIAGNOSIS; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; COST-BENEFIT ANALYSIS; DECISION TREES; FRANCE; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HOSPITAL COSTS; HOSPITALS, TEACHING; HUMANS; PROBABILITY; RISK ASSESSMENT; SEROLOGIC TESTS;

EID: 0037319155     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502170     Document Type: Article

References (23)

1. Aubuchon JP, Birkmeyer JD, Busch MP. Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion 1997;37:45-51.
2. Aubuchon JP, Birkmeyer JD, Busch MP. Safety of the blood supply in the United States: opportunities and controversies. Ann Intern Med 1997;127:904-909.
3. Aubuchon JP, Kruskall MS. Transfusion safety: realigning effort with risks. Transfusion 1997;37:1211-1216.
4. Pereira A. Health and economic consequences of HCV lookback. Transfusion 2001;41:832-839.
5. Morel P, Hervé P. Surveillance of blood transfusion safety: contribution of the hemovigilance strategy in France. Transfus Med Rev 1998;12:109-127.
6. o96,609 du ler octobre 1996 relative aux analyses et tests pratiqués sur des receveurs de produits sanguins labiles. Bulletin Officiel de la République Française 1996;123-128.
7. Mushlin AI, Ruchlin HS, Callahan MA. Cost-effectiveness of diagnostics test. Lancet 2001;358:1353-1355.
8. Aubuchon JP. The role of decision analysis in transfusion medicine. Vox Sang 1996;71:1-5.
9. Drummond MF. Allocating resources. Int J Technol Assess Health Care 1990;6:77-92.
10. Whyte G. Risk management in blood transfusion services. Vox Sang 1998;74:105-109.
11. Detsky AS, Naglie G, Khran M, Redelmeier DA, Naimark D. Primer on medical decision analysis: II. Building a tree. Med Decis Making 1997;17:126-135.
12. Khran M, Naglie G, Naimark D, Redelmeier DA, Detsky AS. Primer on medical decision analysis: IV. Analyzing the model and interpreting the results. Med Decis Making 1997;17:142-151.
13. Naglie G, Khran M, Naimark D, Redelmeier DA, Detsky AS. Primer on medical decision analysis: III. Estimating probabilities and utilities. Med Decis Making 1997;17:136-141.
14. Siegel JE, Weinstein MC, Russel LB, Gold MR, for the panel on Cost-Effectiveness in Health Medicine. Recommendations for reporting cost-effectiveness analyses. JAMA 1996;276:1339-1341.
15. Vicariot M, Marion V, Murati M. Suivi de 2100 malades transfuses au CHU de Brest. Gazette de la Transfusion 1994;104:5-9.
16. Vamvakas EC, Taswell HE. Mortality after blood transfusion. Transfus Med Rev 1994;8:267-280.
17. Mathoulin-Pélissier S, Vicariot M, Gross S, et al. Étude pilote des caractéristiques des patients transfusés et des produits sanguins labiles utilisés. Transfus Clin Biol 1997;4:533-540.
18. Mathoulin-Pélissier S, Vicariot M, Courtois F, et al. Faisabilité d'un suivi de patients transfusés. Transfus Clin Biol 1998;5:266-274.
19. Laperche S, pour le groupe de travail des Hépatites virales et Retrovirus. Réflexions concernant le dépistage des acides nucléiques des virus des hépatites B et C et du virus de l'immunodéficience humaine dans la qualification biologique des dons. Transfus Clin Biol 1998;5:139-146.
20. Agence française du sang. La rénovation du service public transfusionnel: les assurances en transfusion. In: Rapport sur l'activité de transfusion sanguine (juillet 1995-juillet 1996). Paris: La documentation française; 1997:100-103.
21. Morrison AS. Screening. In: Rothman KJ, Greenland S, eds. Modern Epidemiology, 2nd ed. Philadelphia: Lippincott-Raven; 1998:499-518.
22. Salmi LR, Mathoulin S, Perez P, Lawson-Ayayi S. Dépistage et détection précoce en transfusion sanguine: quand sont-ils indiqués? Transfus Clin Biol 1997;4:417-427.
23. Regan FA, Hewitt P, Barbara JA, Contreras M. Prospective investigation of transfusion transmitted infection in recipients of over 20,000 units of blood. BMJ 2000;320:403-406.